Medical Analysis Systems, Inc. Sustainability Profile
Medical Analysis Systems, Inc., commonly referred to as MAS, is a leading provider of innovative healthcare solutions headquartered in the United States. Founded in the early 2000s, the company has established a strong presence in major operational regions across North America and Europe, focusing on the medical diagnostics and health informatics sectors. MAS is renowned for its cutting-edge diagnostic tools and data analysis services, which enhance patient care and streamline clinical workflows. The company’s unique approach combines advanced technology with user-friendly interfaces, setting it apart in a competitive market. With a commitment to quality and innovation, MAS has achieved significant milestones, including partnerships with prominent healthcare institutions and recognition for its contributions to medical research. As a trusted name in the industry, Medical Analysis Systems, Inc. continues to shape the future of healthcare through its comprehensive solutions.
DitchCarbon Score
How does Medical Analysis Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medical Analysis Systems, Inc.'s score of 94 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medical Analysis Systems, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. As a current subsidiary of Thermo Fisher Scientific Inc., any emissions data or climate commitments would be inherited from this parent organisation. Thermo Fisher Scientific Inc. has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Medical Analysis Systems, Inc. are not detailed in the available information. As part of its corporate family, Medical Analysis Systems, Inc. aligns with the broader sustainability goals set by Thermo Fisher Scientific Inc., which may include commitments to reduce emissions across Scope 1, 2, and 3 categories. Nonetheless, without specific data or targets outlined for Medical Analysis Systems, Inc., it is challenging to provide a detailed overview of their carbon emissions and climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Medical Analysis Systems, Inc.'s Industry?
How Carbon Intensive is Medical Analysis Systems, Inc.'s Location?
Medical Analysis Systems, Inc.'s Scope 3 Categories Breakdown
Medical Analysis Systems, Inc.'s Scope 3 emissions, which decreased by 13% last year and decreased by approximately 15% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Medical Analysis Systems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medical Analysis Systems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
